Knowledge and Attitude Among Healthcare Workers Towards Malaria Vaccine, Sudan 2025.

NCT ID: NCT07194499

Last Updated: 2025-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

222 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-16

Study Completion Date

2025-04-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study assesses Sudanese healthcare workers' knowledge and attitudes toward the malaria vaccine in 2025, considering demographic and professional factors. It examines awareness of malaria prevalence, WHO recommendations, vaccine type, efficacy, and safety, along with confidence in recommending it and its acceptability. The findings will aid in designing interventions to improve vaccine uptake and reduce malaria burden.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to assess the knowledge and attitudes of Sudanese healthcare workers (HCWs) toward the malaria vaccine in 2025. It examines how demographic factors and professional roles influence their understanding and perception. The knowledge assessment includes awareness of malaria prevalence, WHO vaccine recommendations, and vaccine type, efficacy, and safety. The attitude evaluation focuses on confidence in recommending the vaccine and perceptions of its feasibility and acceptance in Sudan. The findings will help design targeted interventions to enhance vaccine uptake and reduce the malaria burden.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malaria Malaria Vaccine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No interventions

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Graduates of healthcare profession fields with at least one year of healthcare practice following graduation.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Research and Publication office

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research and Publication Office

Khartoum, Khartoum State, Sudan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sudan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Malaria Prevalence in Children
NCT00322816 COMPLETED